The Cornelia de Lange Syndrome (CdLS) Foundation announces the availability of funding for basic science and clinical research in 2015. Letters of intent and applications are accepted beginning January 15, 2015.
CdLS is genetic condition causing a range of medical, developmental and physical challenges. It is a cohesinopathy caused by mutations in any one of the following genes: NIPBL, SMC1A, SMC3, HDAC8 and RAD21. Only 70 percent of individuals tested to date have a change in any of the mentioned genes, with the majority having an NIPBL mutation.
Timeline
Letters of Intent deadline: April 15, 2015
Application deadline: May 15, 2015
Award notification: July 15, 2015
Grant checks mailed: September 1, 2015
Visit https://www.cdlsusa.org/research/grants.htm for guidelines and submission information.
Stay Connected
Sign up for updates straight to your inbox.